The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia

O. Shchudro (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine)

Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Session: Pulmonary rehabilitation in the COVID-19 era
Session type: E-poster
Number: 611

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Shchudro (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine). The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia. 611

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021


Does carbon monoxide diffusing capacity (DLCO) effect results of pulmonary rehabilitation?
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015

Alcohol effects on diffusing capacity of the lung for carbon monoxide (DLCO) in healthy subjects and in COPD patients
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010

Mechanisms of exertional dyspnea in patients with mild COPD and low resting lung diffusing capacity for carbon monoxide (DLCO)
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020


Diffusing capacity of the lung for carbon monoxide (DLCO) and pulmonary blood flow during incremental and intermittent-work exercise tests
Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange
Year: 2008


Roles of transthoracic lung ultrasonography in diagnosis of interstitial lung disease: correlation with  HRCT, vital capacity, diffusing of the lung for monoxide test
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Carbon monoxide diffusing capacity (DLCO) usefulness in patients suffering from exertional dyspnea with or without oxygen desaturation during exercise testing
Source: Eur Respir J 2002; 20: Suppl. 38, 491s
Year: 2002

Elevation of diffusing lung capacity (TLCO) in asthmatic children as a result of ventilation/perfusion disorder
Source: Eur Respir J 2003; 22: Suppl. 45, 495s
Year: 2003

Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 963-965
Year: 2014


Does the decrease in KCO go typically with DLCO decrease in obstructive pulmonary diseases? The relationship with DLCO, KCO, VA and VA/TLC in patients with COPD>
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018

Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO)
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008


Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015

No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib
Source: International Congress 2016 – IPF treatment II
Year: 2016



CO diffusing capacity: are adjustments of CO diffusing capacity necessary?
Source: Annual Congress 2006 - Implementation of the new standards on clinical pulmonary function testing
Year: 2006


Evaluation of HRCT, pulmonary function tests, alveolar-arterial oxygen tension gradient, DLCO in patients with chronic HCV infection
Source: Eur Respir J 2003; 22: Suppl. 45, 43s
Year: 2003

Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011


Reliability of diffusing capacity of lung carbon monoxide (DLCO) measurements at 2, 4, and 6 minute time intervals in healthy normals
Source: International Congress 2014 – Respiratory function at rest and during exercise
Year: 2014


Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007